|
EP0642355B1
(en)
|
1992-05-23 |
1998-07-15 |
SMITHKLINE BEECHAM BIOLOGICALS s.a. |
Combined vaccines comprising hepatitis b surface antigen and other antigens
|
|
US6468765B1
(en)
|
1995-04-21 |
2002-10-22 |
Human Genome Sciences, Inc. |
Selected Haemophilus influenzae Rd polynucleotides and polypeptides
|
|
US6355450B1
(en)
|
1995-04-21 |
2002-03-12 |
Human Genome Sciences, Inc. |
Computer readable genomic sequence of Haemophilus influenzae Rd, fragments thereof, and uses thereof
|
|
US6696065B1
(en)
|
1995-05-04 |
2004-02-24 |
Aventis Pastuer Limited |
Acellular pertussis vaccines and methods of preparation thereof
|
|
PL184872B1
(pl)
*
|
1995-06-23 |
2003-01-31 |
Smithkline Beecham Biolog |
Kombinowana szczepionkaĆ zestaw do przygotowania kombinowanej szczepionkiĆ sposób wytwarzania kombinowanej szczepionki i jej zastosowanie
|
|
CN100408095C
(zh)
*
|
1996-07-02 |
2008-08-06 |
康诺特实验室有限公司 |
多价dtp-polio疫苗
|
|
GB9806456D0
(en)
*
|
1998-03-25 |
1998-05-27 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
DK1126876T3
(da)
*
|
1998-10-16 |
2007-07-02 |
Glaxosmithkline Biolog Sa |
Adjuvanssystemer og vacciner
|
|
US6585973B1
(en)
*
|
1998-10-29 |
2003-07-01 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Method for preparing solid phase conjugated vaccine
|
|
GB9928196D0
(en)
|
1999-11-29 |
2000-01-26 |
Chiron Spa |
Combinations of B, C and other antigens
|
|
GB0108364D0
(en)
|
2001-04-03 |
2001-05-23 |
Glaxosmithkline Biolog Sa |
Vaccine composition
|
|
PT1946769E
(pt)
|
2000-06-29 |
2012-06-27 |
Smithkline Beecham Biolog |
Composição de vacina multivalente com dose reduzida de haemophilus influenzae de tipo b
|
|
KR100947757B1
(ko)
|
2001-01-23 |
2010-03-18 |
아벤티스 파스퇴르 |
다가 수막구균 폴리사카라이드―단백질 접합체 백신
|
|
GB0115176D0
(en)
*
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
EP2353608B1
(en)
|
2002-10-11 |
2019-12-18 |
Novartis Vaccines and Diagnostics S.r.l. |
Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
|
|
ATE352316T1
(de)
*
|
2002-11-01 |
2007-02-15 |
Glaxosmithkline Biolog Sa |
Immunogene zusammensetzung
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
ES2461350T3
(es)
|
2003-01-30 |
2014-05-19 |
Novartis Ag |
Vacunas inyectables contra múltiples serogrupos de meningococos
|
|
GB0313916D0
(en)
|
2003-06-16 |
2003-07-23 |
Glaxosmithkline Biolog Sa |
Vaccine composition
|
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
|
ES2346314T3
(es)
*
|
2003-10-02 |
2010-10-14 |
Glaxosmithkline Biolog Sa |
Antigenos de b. pertussis y uso de los mismos en vacunacion.
|
|
PT1961426E
(pt)
|
2003-10-02 |
2011-06-28 |
Novartis Vaccines & Diagnostic |
Vacinas combinadas contra a meningite
|
|
GB0405787D0
(en)
*
|
2004-03-15 |
2004-04-21 |
Chiron Srl |
Low dose vaccines
|
|
GB0409745D0
(en)
|
2004-04-30 |
2004-06-09 |
Chiron Srl |
Compositions including unconjugated carrier proteins
|
|
GB0500787D0
(en)
|
2005-01-14 |
2005-02-23 |
Chiron Srl |
Integration of meningococcal conjugate vaccination
|
|
EP1740217B1
(en)
|
2004-04-30 |
2011-06-15 |
Novartis Vaccines and Diagnostics S.r.l. |
Meningococcal conjugate vaccination
|
|
GB0505518D0
(en)
|
2005-03-17 |
2005-04-27 |
Chiron Srl |
Combination vaccines with whole cell pertussis antigen
|
|
GB0505996D0
(en)
|
2005-03-23 |
2005-04-27 |
Glaxosmithkline Biolog Sa |
Fermentation process
|
|
JP2008536515A
(ja)
|
2005-04-18 |
2008-09-11 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド |
ワクチンの調製のためのｂ型肝炎ウイルス表面抗原の発現
|
|
ATE536884T1
(de)
|
2005-06-27 |
2011-12-15 |
Glaxosmithkline Biolog Sa |
Immunogene zusammensetzung
|
|
GB0522765D0
(en)
|
2005-11-08 |
2005-12-14 |
Chiron Srl |
Combination vaccine manufacture
|
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
|
ES2383209T3
(es)
|
2006-03-22 |
2012-06-19 |
Novartis Ag |
Regímenes para la inmunización con conjugados meningococicos
|
|
US10828361B2
(en)
|
2006-03-22 |
2020-11-10 |
Glaxosmithkline Biologicals Sa |
Regimens for immunisation with meningococcal conjugates
|
|
NZ575273A
(en)
|
2006-09-07 |
2012-02-24 |
Glaxosmithkline Biolog Sa |
Method for making combination vaccine comprising inactivated poliovirus type 1, diptheria toxoid and tetanus toxoid
|
|
WO2008135514A1
(en)
|
2007-05-02 |
2008-11-13 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
|
AU2008259423A1
(en)
|
2007-06-04 |
2008-12-11 |
Novartis Ag |
Formulation of meningitis vaccines
|
|
FR2918671B1
(fr)
*
|
2007-07-10 |
2010-10-15 |
Sanofi Pasteur |
Milieu de culture d'haemophilus influenzae type b.
|
|
GB0818453D0
(en)
|
2008-10-08 |
2008-11-12 |
Novartis Ag |
Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
|
|
GB0822633D0
(en)
|
2008-12-11 |
2009-01-21 |
Novartis Ag |
Formulation
|
|
TW201043267A
(en)
*
|
2009-03-19 |
2010-12-16 |
Intervet Int Bv |
In situ constituting a vaccine for administration to a predetermined herd of animals
|
|
LT2411048T
(lt)
*
|
2009-03-24 |
2020-06-25 |
Glaxosmithkline Biologicals Sa |
Adjuvantinį meningokokinį faktorių h surišantis baltymas
|
|
IT1398927B1
(it)
|
2009-06-25 |
2013-03-28 |
Consorzio Interuniversitario Per Lo Sviluppo Dei Sistemi A Grande Interfase Csgi |
Espressione batterica di un gene artificiale per la produzione di crm197 e derivati.
|
|
GB0917647D0
(en)
|
2009-10-08 |
2009-11-25 |
Glaxosmithkline Biolog Sa |
Expression system
|
|
RU2705163C2
(ru)
|
2011-01-05 |
2019-11-05 |
Бхарат Байотек Интернэшнл Лимитед |
Комбинированная семивалентная вакцина
|
|
GB201105981D0
(en)
|
2011-04-08 |
2011-05-18 |
Glaxosmithkline Biolog Sa |
Novel process
|
|
TW201302779A
(zh)
|
2011-04-13 |
2013-01-16 |
Glaxosmithkline Biolog Sa |
融合蛋白質及組合疫苗
|
|
EP2592137A1
(en)
|
2011-11-11 |
2013-05-15 |
Novartis AG |
Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use
|
|
DE102011118371B4
(de)
|
2011-11-11 |
2014-02-13 |
Novartis Ag |
Zur Impfung von Menschen geeignete Zusammensetzung, die ein Diphtherie-Toxoid umfasst, sowie Verfahren zu deren Herstellung
|
|
GB2495341B
(en)
|
2011-11-11 |
2013-09-18 |
Novartis Ag |
Fermentation methods and their products
|
|
DE102011122891B4
(de)
|
2011-11-11 |
2014-12-24 |
Novartis Ag |
Fermentationsmedium, das frei von tierischen Bestandteilen ist, zur Herstellung von Diphtherie-Toxoiden zur Verwendung bei der Impfung von Menschen
|
|
CN104093416B
(zh)
|
2012-02-01 |
2016-10-19 |
葛兰素史密丝克莱恩生物有限公司 |
发酵方法
|
|
CN104487086B
(zh)
*
|
2012-07-07 |
2019-08-30 |
巴拉特生物技术国际有限公司 |
无动物源的不含酒精的疫苗组合物及其制备方法
|
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
|
SG11201500573RA
(en)
|
2012-08-06 |
2015-02-27 |
Glaxosmithkline Biolog Sa |
Method for eliciting in infants an immune response against rsv and b. pertussis
|
|
WO2014057132A1
(en)
|
2012-10-12 |
2014-04-17 |
Novartis Ag |
Non-cross-linked acellular pertussis antigens for use in combination vaccines
|
|
BR112016002354A2
(pt)
|
2013-08-05 |
2017-09-12 |
Glaxosmithkline Biologicals Sa |
composição imunogênica, métodos para proteger um bebê contra infecção ou doença e para evocar uma resposta imune, regime de vacinação, e, kit
|
|
US11219680B2
(en)
|
2017-02-24 |
2022-01-11 |
Merck Sharp & Dohme Corp. |
Polysaccharide-protein conjugates utilizing diphtheria toxin fragment B as a carrier
|
|
JP7404226B2
(ja)
|
2017-07-18 |
2023-12-25 |
セラム インスティテュート オブ インディア プライベート リミティド |
向上した安定性、高度の免疫原性、及び減少した反応源性を有する免疫原性組成物、並びにその調製プロセス
|
|
JOP20190242A1
(ar)
|
2018-10-12 |
2020-04-12 |
Serum Institute Of India Pvt Ltd |
تركيبة لقاح توليفي تشمل فيروس شلل الأطفال ذو جرعة مخفّضة خاملة التنشيط وطريقة لتحضيرها
|
|
CN114302737A
(zh)
|
2019-05-20 |
2022-04-08 |
索利吉尼克斯公司 |
制造三价线状病毒疫苗的组合物和方法
|
|
CN111658617A
(zh)
*
|
2019-10-14 |
2020-09-15 |
四川大学 |
一种含铝佐剂疫苗的冻干制剂及其制备方法和用途
|